{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:07:39Z","timestamp":1791378459906,"version":"4.3.2"},"reference-count":124,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.hoc.2024.11.007","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T20:40:02Z","timestamp":1734468002000},"page":"377-397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Heavy Ion Particle Therapy in Modern Day Radiation Oncology"],"prefix":"10.1016","volume":"39","author":[{"given":"Xiaoying","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homan","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn C.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.","family":"Beltran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.hoc.2024.11.007_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.soncn.2018.03.006","article-title":"The evolution of radiation therapy in treating cancer","volume":"34","author":"Abshire","year":"2018","journal-title":"Semin Oncol Nurs"},{"issue":"8","key":"10.1016\/j.hoc.2024.11.007_bib2","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41416-019-0412-y","article-title":"How rapid advances in imaging are defining the future of precision radiation oncology","volume":"120","author":"Beaton","year":"2019","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.hoc.2024.11.007_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10147-013-0556-3","article-title":"Evolution of the techniques of radiation therapy in the management of lymphoma","volume":"18","author":"Hoppe","year":"2013","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.hoc.2024.11.007_bib4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fonc.2020.00082","article-title":"Carbon ion therapy: a modern review of an emerging technology","volume":"10","author":"Malouff","year":"2020","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.hoc.2024.11.007_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/acm2.13133","article-title":"We are ready for clinical implementation of Carbon Ion Radiotherapy in the United States","volume":"21","author":"Beltran","year":"2020","journal-title":"J\u00a0Appl Clin Med Phys"},{"key":"10.1016\/j.hoc.2024.11.007_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.954747","article-title":"The majority of United States citizens with cancer do not have access to carbon ion radiotherapy","volume":"12","author":"Foote","year":"2022","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2024.11.007_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.14338\/IJPT-19-00079.1","article-title":"Estimating the number of patients eligible for carbon ion radiotherapy in the United States","volume":"7","author":"Malouff","year":"2020","journal-title":"Int J Part Ther. Fall"},{"issue":"3","key":"10.1016\/j.hoc.2024.11.007_bib8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.coms.2023.02.003","article-title":"Proton radiotherapy for skull-base malignancies: imaging considerations of radiotherapy and complications","volume":"35","author":"Holtzman","year":"2023","journal-title":"Oral Maxillofac Surg Clin"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.007_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.14338\/IJPT-20-00066.1","article-title":"Clinical outcomes following dose-escalated proton therapy for skull-base chordoma","volume":"8","author":"Holtzman","year":"2021","journal-title":"Int J Part Ther. Summer"},{"issue":"4","key":"10.1016\/j.hoc.2024.11.007_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx208","article-title":"Quality of life and patient-reported outcomes following proton radiation therapy: a systematic review","volume":"110","author":"Verma","year":"2018","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"16_suppl","key":"10.1016\/j.hoc.2024.11.007_bib11","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1200\/JCO.2024.42.16_suppl.6006","article-title":"Phase III randomized trial of intensity-modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for the treatment of head and neck oropharyngeal carcinoma (OPC)","volume":"42","author":"Frank","year":"2024","journal-title":"J\u00a0Clin Oncol"},{"issue":"15","key":"10.1016\/j.hoc.2024.11.007_bib12","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1002\/cncr.32938","article-title":"Second cancer risk after primary cancer treatment with three-dimensional conformal, intensity-modulated, or proton beam radiation therapy","volume":"126","author":"Xiang","year":"2020","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.hoc.2024.11.007_bib13","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.semradonc.2017.11.007","article-title":"Can technological improvements reduce the cost of proton radiation therapy?","volume":"28","author":"Schippers","year":"2018","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.hoc.2024.11.007_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.930850","article-title":"Considerations for upright particle therapy patient positioning and associated image guidance","volume":"12","author":"Volz","year":"2022","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2024.11.007_bib15","doi-asserted-by":"crossref","first-page":"180","DOI":"10.21037\/tlcr.2018.03.28","article-title":"Proton beam therapy and immunotherapy: an emerging partnership for immune activation in non-small cell lung cancer","volume":"7","author":"Lee","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.hoc.2024.11.007_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.radonc.2019.10.005","article-title":"RBE-weighted dose conversions for carbon ionradiotherapy between microdosimetric kinetic model and local effect model for the targets and organs at risk in prostate carcinoma","volume":"144","author":"Wang","year":"2020","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.hoc.2024.11.007_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27051540","article-title":"DNA damage clustering after ionizing radiation and consequences in the processing of chromatin breaks","volume":"27","author":"Mladenova","year":"2022","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.hoc.2024.11.007_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13061356","article-title":"A\u00a0potential renewed use of very heavy ions for therapy: neon minibeam radiation therapy","volume":"13","author":"Prezado","year":"2021","journal-title":"Cancers"},{"issue":"18","key":"10.1016\/j.hoc.2024.11.007_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15184494","article-title":"Carbon ions for hypoxic tumors: are we making the most of them?","volume":"15","author":"Sokol","year":"2023","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.hoc.2024.11.007_bib20","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.3390\/curroncol30060416","article-title":"High-LET-radiation-induced persistent DNA damage response signaling and gastrointestinal cancer development","volume":"30","author":"Kumar","year":"2023","journal-title":"Curr Oncol"},{"issue":"11","key":"10.1016\/j.hoc.2024.11.007_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11111789","article-title":"Ionizing radiation and complex DNA damage: from prediction to detection challenges and biological significance","volume":"11","author":"Mavragani","year":"2019","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.hoc.2024.11.007_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0273-1177(89)90426-2","article-title":"Cell cycle delays induced by heavy ion irradiation of synchronous mammalian cells","volume":"9","author":"Scholz","year":"1989","journal-title":"Adv Space Res"},{"issue":"5","key":"10.1016\/j.hoc.2024.11.007_bib23","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/jrr\/rrad059","article-title":"Radiation-quality-dependent bystander cellular effects induced by heavy-ion microbeams through different pathways","volume":"64","author":"Suzuki","year":"2023","journal-title":"J\u00a0Radiat Res"},{"issue":"4","key":"10.1016\/j.hoc.2024.11.007_bib24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1667\/RR3159.2","article-title":"The LET dependence of unrepaired chromosome damage in human cells: a break too far?","volume":"179","author":"Loucas","year":"2013","journal-title":"Radiat Res"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.007_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1667\/RR3089.1","article-title":"Chromosome damage in human cells by gamma rays, alpha particles and heavy ions: track interactions in basic dose-response relationships","volume":"179","author":"Loucas","year":"2013","journal-title":"Radiat Res"},{"issue":"4","key":"10.1016\/j.hoc.2024.11.007_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14040976","article-title":"Dissecting tumor growth: the role of cancer stem cells in drug resistance and recurrence","volume":"14","author":"Aramini","year":"2022","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.hoc.2024.11.007_bib27","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.3892\/or.2015.4236","article-title":"Cancer stem cells: the potential of carbon ion beam radiation and new radiosensitizers (Review)","volume":"34","author":"Baek","year":"2015","journal-title":"Oncol Rep"},{"issue":"1 Suppl 1","key":"10.1016\/j.hoc.2024.11.007_bib28","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/MD.0000000000004766","article-title":"Cancer stem cells: role in tumor growth, recurrence, metastasis, and treatment resistance","volume":"95","author":"Chang","year":"2016","journal-title":"Medicine (Baltim)"},{"issue":"9","key":"10.1016\/j.hoc.2024.11.007_bib29","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1118\/1.3187229","article-title":"Anderson proton therapy system","volume":"36","author":"Smith","year":"2009","journal-title":"Med Phys"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.007_bib30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.nima.2010.09.016","article-title":"Multiple-energy operation with extended flattops at HIMAC","volume":"624","author":"Iwata","year":"2010","journal-title":"Nucl Instrum Methods Phys Res"},{"key":"10.1016\/j.hoc.2024.11.007_bib31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.nimb.2013.12.033","article-title":"Experimental studies of systematic multiple-energy operation at HIMAC synchrotron","volume":"331","author":"Mizushima","year":"2014","journal-title":"Nucl Instrum Methods Phys Res B"},{"issue":"3","key":"10.1016\/j.hoc.2024.11.007_bib32","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.adro.2018.02.006","article-title":"Multiple energy extraction reduces beam delivery time for a synchrotron-based proton spot-scanning system","volume":"3","author":"Younkin","year":"2018","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.007_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nima.2010.09.028","article-title":"Compact superconducting cyclotron C400 for hadron therapy","volume":"624","author":"Jongen","year":"2010","journal-title":"Nucl Instrum Methods Phys Res"},{"issue":"2, Supplement","key":"10.1016\/j.hoc.2024.11.007_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2023.06.2147","article-title":"3496 beam delivery and patient alignment: perspective of the innovative cycloton 400MEV\/u multi-ion system","volume":"117","author":"Letellier","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.hoc.2024.11.007_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15072044","article-title":"Rotating gantries provide individualized beam arrangements for charged particle therapy","volume":"15","author":"Chinniah","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.007_bib36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/physics4010017","article-title":"Hadron therapy achievements and challenges: the CNAO Experience","volume":"4","author":"Rossi","year":"2022","journal-title":"Physics"},{"issue":"3","key":"10.1016\/j.hoc.2024.11.007_bib37","doi-asserted-by":"crossref","first-page":"474","DOI":"10.14338\/IJPT-15-00022.1","article-title":"Development of clinical programs for carbon ion beam therapy at medaustron","volume":"2","author":"Stock","year":"2016","journal-title":"Int J Part Ther. Winter"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.007_bib38","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijrobp.2015.09.033","article-title":"Reassessment of the necessity of the proton gantry: analysis of beam orientations from 4332 treatments at the Massachusetts general hospital proton center over the past 10 years","volume":"95","author":"Yan","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.hoc.2024.11.007_bib39","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/mp.15409","article-title":"Technical note: does the greater power of pencil beam scanning reduce the need for a proton gantry? A study of head-and-neck and brain tumors","volume":"49","author":"Yan","year":"2022","journal-title":"Med Phys"},{"issue":"3","key":"10.1016\/j.hoc.2024.11.007_bib40","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/jrr\/rrs114","article-title":"Systematic analysis of RBE and related quantities using a database of cell survival experiments with ion beam irradiation","volume":"54","author":"Friedrich","year":"2013","journal-title":"J\u00a0Radiat Res"},{"issue":"5","key":"10.1016\/j.hoc.2024.11.007_bib41","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1667\/0033-7587(2000)154[0485:IOAAHC]2.0.CO;2","article-title":"Inactivation of aerobic and hypoxic cells from three different cell lines by accelerated (3)He-(12)C- and (20)Ne-ion beams","volume":"154","author":"Furusawa","year":"2000","journal-title":"Radiat Res"},{"issue":"11","key":"10.1016\/j.hoc.2024.11.007_bib42","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1080\/095530099139232","article-title":"RBE for carbon track-segment irradiation in cell lines of differing repair capacity","volume":"75","author":"Weyrather","year":"1999","journal-title":"Int J Radiat Biol"},{"issue":"3","key":"10.1016\/j.hoc.2024.11.007_bib43","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2307\/3579114","article-title":"A\u00a0statistical theory of cell killing by radiation of varying linear energy transfer","volume":"140","author":"Hawkins","year":"1994","journal-title":"Radiat Res"},{"issue":"6","key":"10.1016\/j.hoc.2024.11.007_bib44","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1080\/095530096145481","article-title":"A\u00a0microdosimetric-kinetic model of cell death from exposure to ionizing radiation of any LET, with experimental and clinical applications","volume":"69","author":"Hawkins","year":"1996","journal-title":"Int J Radiat Biol"},{"issue":"7 Pt 1","key":"10.1016\/j.hoc.2024.11.007_bib45","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1118\/1.598307","article-title":"A\u00a0microdosimetric-kinetic theory of the dependence of the RBE for cell death on LET","volume":"25","author":"Hawkins","year":"1998","journal-title":"Med Phys"},{"issue":"4","key":"10.1016\/j.hoc.2024.11.007_bib46","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1667\/RR0536.1","article-title":"Microdosimetric measurements and estimation of human cell survival for heavy-ion beams","volume":"166","author":"Kase","year":"2006","journal-title":"Radiat Res"},{"issue":"22","key":"10.1016\/j.hoc.2024.11.007_bib47","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1088\/0031-9155\/55\/22\/008","article-title":"Treatment planning for a scanned carbon beam with a modified microdosimetric kinetic model","volume":"55","author":"Inaniwa","year":"2010","journal-title":"Phys Med Biol"},{"issue":"8","key":"10.1016\/j.hoc.2024.11.007_bib48","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1088\/0031-9155\/60\/8\/3271","article-title":"Reformulation of a clinical-dose system for carbon-ion radiotherapy treatment planning at the National Institute of Radiological Sciences, Japan","volume":"60","author":"Inaniwa","year":"2015","journal-title":"Phys Med Biol"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.007_bib49","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/aa9a68","article-title":"A\u00a0modified microdosimetric kinetic model for relative biological effectiveness calculation","volume":"63","author":"Chen","year":"2017","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.hoc.2024.11.007_bib50","first-page":"32","article-title":"Effect of heterogeneous radio sensitivity on the survival, alpha beta ratio and biologic effective dose calculation of irradiated mammalian cell populations","volume":"4","author":"Hawkins","year":"2017","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.007_bib51","doi-asserted-by":"crossref","first-page":"8287","DOI":"10.1038\/s41598-018-26556-5","article-title":"Investigation of dose-rate effects and cell-cycle distribution under protracted exposure to ionizing radiation for various dose-rates","volume":"8","author":"Matsuya","year":"2018","journal-title":"Sci Rep"},{"issue":"20","key":"10.1016\/j.hoc.2024.11.007_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012491","article-title":"The Mayo Clinic Florida Microdosimetric kinetic model of clonogenic survival: application to various repair-competent rodent and human cell lines","volume":"23","author":"Parisi","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"18","key":"10.1016\/j.hoc.2024.11.007_bib53","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ac7375","article-title":"The Mayo Clinic Florida microdosimetric kinetic model of clonogenic survival: formalism and first benchmark againstin\u00a0vitroandin silicodata","volume":"67","author":"Parisi","year":"2022","journal-title":"Phys Med Biol"},{"issue":"4","key":"10.1016\/j.hoc.2024.11.007_bib54","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.ijrobp.2010.05.014","article-title":"Quantification of the relative biological effectiveness for ion beam radiotherapy: direct experimental comparison of proton and carbon ion beams and a novel approach for treatment planning","volume":"78","author":"Elsasser","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1\u20132","key":"10.1016\/j.hoc.2024.11.007_bib55","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/09553002.2011.611213","article-title":"Calculation of the biological effects of ion beams based on the microscopic spatial damage distribution pattern","volume":"88","author":"Friedrich","year":"2012","journal-title":"Int J Radiat Biol"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.007_bib56","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s004110050055","article-title":"Computation of cell survival in heavy ion beams for therapy. The model and its approximation","volume":"36","author":"Scholz","year":"1997","journal-title":"Radiat Environ Biophys"},{"key":"10.1016\/j.hoc.2024.11.007_bib57","author":"Friedrich"},{"issue":"9","key":"10.1016\/j.hoc.2024.11.007_bib58","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ac5fdf","article-title":"On the calculation of the relative biological effectiveness of ion radiation therapy using a biological weighting function, the microdosimetric kinetic model (MKM) and subsequent corrections (non-Poisson MKM and modified MKM)","volume":"67","author":"Parisi","year":"2022","journal-title":"Phys Med Biol"},{"issue":"11","key":"10.1016\/j.hoc.2024.11.007_bib59","doi-asserted-by":"crossref","first-page":"e925","DOI":"10.1002\/mp.13207","article-title":"A\u00a0comparison of mechanism-inspired models for particle relative biological effectiveness (RBE)","volume":"45","author":"Stewart","year":"2018","journal-title":"Med Phys"},{"key":"10.1016\/j.hoc.2024.11.007_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.531344","article-title":"Brainstem NTCP and dose constraints for carbon ion RT-application and translation from Japanese to European RBE-Weighted Dose","volume":"10","author":"Dale","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.hoc.2024.11.007_bib61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.radonc.2019.06.028","article-title":"Optic nerve constraints for carbon ion RT at CNAO - reporting and relating outcome to European and Japanese RBE","volume":"140","author":"Dale","year":"2019","journal-title":"Radiother Oncol"},{"issue":"22","key":"10.1016\/j.hoc.2024.11.007_bib62","doi-asserted-by":"crossref","first-page":"7543","DOI":"10.1088\/0031-9155\/57\/22\/7543","article-title":"Dose prescription in carbon ion radiotherapy: a planning study to compare NIRS and LEM approaches with a clinically-oriented strategy","volume":"57","author":"Fossati","year":"2012","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.hoc.2024.11.007_bib63","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.radonc.2022.08.008","article-title":"Organs at risk dose constraints in carbon ion radiotherapy at MedAustron: Translations between LEM and MKM RBE models and preliminary clinical results","volume":"175","author":"Grosshagauer","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.hoc.2024.11.007_bib64","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.radonc.2019.08.022","article-title":"RBE-weighted dose in carbon ion therapy for ACC patients: impact of the RBE model translation on treatment outcomes","volume":"141","author":"Molinelli","year":"2019","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2024.11.007_bib65","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.radonc.2016.05.031","article-title":"Dose prescription in carbon ion radiotherapy: how to compare two different RBE-weighted dose calculation systems","volume":"120","author":"Molinelli","year":"2016","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2024.11.007_bib66","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ijrobp.2012.01.038","article-title":"Mapping of RBE-weighted doses between HIMAC- and LEM-Based treatment planning systems for carbon ion therapy","volume":"84","author":"Steinstrater","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.007_bib67","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13014-020-01723-z","article-title":"RBE-weighted dose conversions for patients with recurrent nasopharyngeal carcinoma receiving carbon-ion radiotherapy from the local effect model to the microdosimetric kinetic model","volume":"15","author":"Zhang","year":"2020","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2024.11.007_bib68","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0360-3016(93)90233-L","article-title":"Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council","volume":"27","author":"Laramore","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.hoc.2024.11.007_bib69","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00000421-199304000-00018","article-title":"Fast neutron radiotherapy for locally advanced prostate cancer. Final report of Radiation Therapy Oncology Group randomized clinical trial","volume":"16","author":"Laramore","year":"1993","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2024.11.007_bib70","doi-asserted-by":"crossref","first-page":"59","DOI":"10.14338\/IJPT-22-00017","article-title":"Fast and furious: fast neutron therapy in cancer treatment","volume":"9","author":"Gordon","year":"2022","journal-title":"Int J Part Ther. Fall"},{"issue":"3","key":"10.1016\/j.hoc.2024.11.007_bib71","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ijrobp.2022.03.006","article-title":"The radiosensitivity index gene signature identifies distinct tumor immune microenvironment characteristics associated with susceptibility to radiation therapy","volume":"113","author":"Grass","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.hoc.2024.11.007_bib72","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1470-2045(16)30648-9","article-title":"A\u00a0genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study","volume":"18","author":"Scott","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hoc.2024.11.007_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.888446","article-title":"Emerging role of carbon ion radiotherapy in reirradiation of recurrent head and neck cancers: what have we achieved so far?","volume":"12","author":"Bhattacharyya","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.007_bib74","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1038\/s41598-019-39241-y","article-title":"Salvage carbon-ion radiation therapy for locoregionally recurrent head and neck malignancies","volume":"9","author":"Gao","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.007_bib75","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13014-020-01625-0","article-title":"Carbon ion reirradiation compared to intensity-modulated re-radiotherapy for recurrent head and neck cancer (CARE): a randomized controlled trial","volume":"15","author":"Held","year":"2020","journal-title":"Radiat Oncol"},{"issue":"20","key":"10.1016\/j.hoc.2024.11.007_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15205021","article-title":"Carbon ion radiotherapy: an evidence-based review and summary recommendations of clinical outcomes for skull-base chordomas and chondrosarcomas","volume":"15","author":"Holtzman","year":"2023","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.hoc.2024.11.007_bib77","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ijrobp.2016.12.028","article-title":"Multicenter study of carbon-ion radiation therapy for mucosal melanoma of the head and neck: subanalysis of the Japan carbon-ion radiation oncology study group (J-CROS) Study (1402 HN)","volume":"97","author":"Koto","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.hoc.2024.11.007_bib78","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.coms.2023.02.009","article-title":"Future perspective: carbon ion radiotherapy for head and neck and skull base malignancies","volume":"35","author":"Rutenberg","year":"2023","journal-title":"Oral Maxillofac Surg Clin"},{"issue":"3","key":"10.1016\/j.hoc.2024.11.007_bib79","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ijrobp.2017.11.010","article-title":"Multicenter study of carbon-ion radiation therapy for adenoid cystic carcinoma of the head and neck: subanalysis of the Japan carbon-ion radiation oncology study group (J-CROS) Study (1402 HN)","volume":"100","author":"Sulaiman","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"19","key":"10.1016\/j.hoc.2024.11.007_bib80","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1002\/cam4.4741","article-title":"Multicenter study of re-irradiation using carbon-ions for head and neck malignancies after photon radiotherapy","volume":"11","author":"Takahashi","year":"2022","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.007_bib81","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijrobp.2016.02.025","article-title":"Acute toxicity and quality of life in patients with prostate cancer treated with protons or carbon ions in a prospective randomized phase II study--The IPI Trial","volume":"95","author":"Habl","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.hoc.2024.11.007_bib82","first-page":"5559","article-title":"Carbon-ion radiotherapy for prostate cancer: analysis of morbidities and change in health-related quality of life","volume":"35","author":"Ishikawa","year":"2015","journal-title":"Anticancer Res"},{"issue":"10","key":"10.1016\/j.hoc.2024.11.007_bib83","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/iju.14041","article-title":"Particle therapy for prostate cancer: the past, present and future","volume":"26","author":"Ishikawa","year":"2019","journal-title":"Int J Urol"},{"issue":"20","key":"10.1016\/j.hoc.2024.11.007_bib84","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1002\/cncr.30050","article-title":"Significant impact of biochemical recurrence on overall mortality in patients with high-risk prostate cancer after carbon-ion radiotherapy combined with androgen deprivation therapy","volume":"122","author":"Kasuya","year":"2016","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.007_bib85","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12885-020-6570-8","article-title":"Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study \"GUNMA0702\"","volume":"20","author":"Kawamura","year":"2020","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.hoc.2024.11.007_bib86","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/jrr\/rrw122","article-title":"Five-year quality of life assessment after carbon ion radiotherapy for prostate cancer","volume":"58","author":"Maruyama","year":"2017","journal-title":"J\u00a0Radiat Res"},{"issue":"2","key":"10.1016\/j.hoc.2024.11.007_bib87","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.radonc.2016.10.009","article-title":"A\u00a0multi-institutional analysis of prospective studies of carbon ion radiotherapy for prostate cancer: a report from the Japan Carbon ion Radiation Oncology Study Group (J-CROS)","volume":"121","author":"Nomiya","year":"2016","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.hoc.2024.11.007_bib88","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/jjco\/hyl030","article-title":"Monotherapy with carbon ion radiation for localized prostate cancer","volume":"36","author":"Shimazaki","year":"2006","journal-title":"Jpn J Clin Oncol"},{"issue":"8","key":"10.1016\/j.hoc.2024.11.007_bib89","first-page":"3267","article-title":"Biochemical failure after carbon ion radiotherapy for prostate cancer","volume":"32","author":"Shimazaki","year":"2012","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.hoc.2024.11.007_bib90","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ijrobp.2005.04.022","article-title":"Hypofractionated radiotherapy with carbon ion beams for prostate cancer","volume":"63","author":"Tsuji","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.hoc.2024.11.007_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112713","article-title":"Multi-institutional retrospective analysis of carbon-ion radiotherapy for patients with locally advanced adenocarcinoma of the uterine cervix","volume":"13","author":"Okonogi","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.hoc.2024.11.007_bib92","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ijrobp.2019.02.042","article-title":"A\u00a0Phase 1\/2 Study of carbon ion radiation therapy with concurrent chemotherapy for locally advanced uterine cervical squamous cell carcinoma (Protocol 1302)","volume":"104","author":"Okonogi","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.hoc.2024.11.007_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127587","article-title":"Clinical trial of prophylactic extended-field carbon-ion radiotherapy for locally advanced uterine cervical cancer (protocol 0508)","volume":"10","author":"Wakatsuki","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.007_bib94","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13014-022-02089-0","article-title":"Efficacy and safety of carbon ion radiotherapy for bone sarcomas: a systematic review and meta-analysis","volume":"17","author":"Dong","year":"2022","journal-title":"Radiat Oncol"},{"issue":"9","key":"10.1016\/j.hoc.2024.11.007_bib95","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1002\/cam4.1679","article-title":"Carbon ion radiotherapy for unresectable localized axial soft tissue sarcoma","volume":"7","author":"Imai","year":"2018","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.hoc.2024.11.007_bib96","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ijrobp.2008.12.019","article-title":"Carbon ion radiotherapy for unresectable retroperitoneal sarcomas","volume":"75","author":"Serizawa","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"20","key":"10.1016\/j.hoc.2024.11.007_bib97","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1002\/cncr.30816","article-title":"Progressive hypofractionated carbon-ion radiotherapy for hepatocellular carcinoma: combined analyses of 2 prospective trials","volume":"123","author":"Kasuya","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.hoc.2024.11.007_bib98","first-page":"19","article-title":"Influence of dose-averaged linear energy transfer on tumour control after carbon-ion radiation therapy for pancreatic cancer","volume":"21","author":"Hagiwara","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"issue":"5","key":"10.1016\/j.hoc.2024.11.007_bib99","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.ijrobp.2018.04.057","article-title":"Multi-institutional study of carbon-ion radiotherapy for locally advanced pancreatic cancer: Japan carbon-ion radiation oncology study group (J-CROS) study 1403 pancreas","volume":"101","author":"Kawashiro","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4 suppl","key":"10.1016\/j.hoc.2024.11.007_bib100","article-title":"A\u00a0phase I dose escalation study of carbon-ion radiotherapy for pancreatic cancer","volume":"41","author":"Shinoto","year":"2023","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.007_bib101","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ijrobp.2015.12.362","article-title":"Carbon ion radiation therapy with concurrent gemcitabine for patients with locally advanced pancreatic cancer","volume":"95","author":"Shinoto","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.hoc.2024.11.007_bib102","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1111\/cas.13727","article-title":"Updated long-term outcomes after carbon-ion radiotherapy for primary renal cell carcinoma","volume":"109","author":"Kasuya","year":"2018","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.007_bib103","doi-asserted-by":"crossref","first-page":"76","DOI":"10.18632\/oncotarget.26539","article-title":"Prospective clinical trial of 12-fraction carbon-ion radiotherapy for primary renal cell carcinoma","volume":"10","author":"Kasuya","year":"2019","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.hoc.2024.11.007_bib104","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ijrobp.2008.01.043","article-title":"Carbon ion radiation therapy for primary renal cell carcinoma: initial clinical experience","volume":"72","author":"Nomiya","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.007_bib105","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41598-022-05809-4","article-title":"Comparison of clinical outcomes between carbon ion radiotherapy and X-ray radiotherapy for reirradiation in locoregional recurrence of rectal cancer","volume":"12","author":"Chung","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.hoc.2024.11.007_bib106","article-title":"Five-year outcomes in carbon-ion radiotherapy for postoperative pelvic recurrence of rectal cancer: a prospective clinical trial (GUNMA 0801)","volume":"44","author":"Shiba","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.hoc.2024.11.007_bib107","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.radonc.2018.10.007","article-title":"Carbon-ion radiotherapy for locally recurrent rectal cancer: Japan carbon-ion radiation oncology study group (J-CROS) study 1404 rectum","volume":"132","author":"Shinoto","year":"2019","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2024.11.007_bib108","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.ijrobp.2023.09.036","article-title":"Carbon-ion radiation therapy for unresectable locally recurrent colorectal cancer: a promising curative treatment for both radiation therapy: naive cases and reirradiation cases","volume":"118","author":"Takiyama","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.007_bib109","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1245\/s10434-021-10876-4","article-title":"Carbon ion radiotherapy for locally recurrent rectal cancer of patients with prior pelvic irradiation","volume":"29","author":"Yamada","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hoc.2024.11.007_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109640","article-title":"Clinical results of carbon ion radiotherapy for inoperable stage I non-small cell lung cancer: a Japanese national registry study (J-CROS-LUNG)","volume":"183","author":"Kubo","year":"2023","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.hoc.2024.11.007_bib111","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/jrr\/rrx037","article-title":"Carbon-ion radiotherapy for patients with advanced stage non-small-cell lung cancer at multicenters","volume":"58","author":"Karube","year":"2017","journal-title":"J\u00a0Radiat Res"},{"issue":"8","key":"10.1016\/j.hoc.2024.11.007_bib112","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/cncr.29195","article-title":"A\u00a0prospective nonrandomized phase I\/II study of carbon ion radiotherapy in a favorable subset of locally advanced non-small cell lung cancer (NSCLC)","volume":"121","author":"Takahashi","year":"2015","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.hoc.2024.11.007_bib113","article-title":"Multi-institutional retrospective analysis of the outcomes of proton beam therapy for patients with 1 to 3 pulmonary oligometastases from various primary cancers","volume":"6","author":"Aibe","year":"2021","journal-title":"Adv Radiat Oncol"},{"issue":"8","key":"10.1016\/j.hoc.2024.11.007_bib114","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/jso.22127","article-title":"A\u00a0phase I\/II clinical trial of preoperative short-course carbon-ion radiotherapy for patients with squamous cell carcinoma of the esophagus","volume":"105","author":"Akutsu","year":"2012","journal-title":"J\u00a0Surg Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2024.11.007_bib115","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s13014-020-01713-1","article-title":"A\u00a0clinical study of curative partial breast irradiation for stage I breast cancer using carbon ion radiotherapy","volume":"15","author":"Karasawa","year":"2020","journal-title":"Radiat Oncol"},{"issue":"2, Supplement","key":"10.1016\/j.hoc.2024.11.007_bib116","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/j.ijrobp.2023.06.1037","article-title":"2389 clinical trials of carbon ion radiotherapy for early-stage breast cancer","volume":"117","author":"Karasawa","year":"2023","journal-title":"Int J Radiat Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2024.11.007_bib117","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1200\/OP.24.00132","article-title":"Proton therapy: current status and controversies","volume":"20","author":"Press","year":"2024","journal-title":"JCO Oncol Pract"},{"issue":"5","key":"10.1016\/j.hoc.2024.11.007_bib118","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.10670","article-title":"Travel-time disparities in access to proton beam therapy for cancer treatment","volume":"7","author":"Burus","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.hoc.2024.11.007_bib119","article-title":"Association of race with receipt of proton beam therapy for patients with newly diagnosed cancer in the US, 2004-2018","volume":"5","author":"Nogueira","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.hoc.2024.11.007_bib120","article-title":"Patterns of care and utilization disparities in proton radiation therapy for pediatric central nervous system malignancies","volume":"7","author":"Weil","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.hoc.2024.11.007_bib121","first-page":"147","article-title":"TORPEdO: a phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer","volume":"38","author":"Thomson","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2024.11.007_bib122","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.ijrobp.2021.03.037","article-title":"Protons versus photons for prostate cancer: an answer that is long overdue and coming","volume":"110","author":"Efstathiou","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2, Supplement","key":"10.1016\/j.hoc.2024.11.007_bib123","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1016\/j.ijrobp.2023.06.1635","article-title":"2980 prostate advanced radiation technologies investigating quality of life (PARTIQoL): a Phase III randomized clinical trial of proton therapy vs. IMRT for low or intermediate risk prostate cancer","volume":"117","author":"Wisdom","year":"2023","journal-title":"Int J Radiat Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2024.11.007_bib124","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15061660","article-title":"Pragmatic, prospective comparative effectiveness trial of carbon ion therapy, surgery, and proton therapy for the management of pelvic sarcomas (Soft Tissue\/Bone) involving the bone: the PROSPER Study rationale and design","volume":"15","author":"Hoppe","year":"2023","journal-title":"Cancers"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858824001527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858824001527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T14:42:30Z","timestamp":1750862550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858824001527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":124,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0889858824001527"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2024.11.007","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heavy Ion Particle Therapy in Modern Day Radiation Oncology","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2024.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}